title: Current Status of Drug-Eluting Stents and Drug-Eluting Balloons for the Superficial Femoral Artery.
abstract: The endovascular management of symptomatic atherosclerotic superficial femoral artery disease is challenging and requires consideration of unique anatomic, hemodynamic, and biomechanical factors. For innovative local drug delivery technologies to have a cost-effective and clinically meaningful benefit, they must provide patency rates in more complex lesions equivalent or superior to those currently approved devices are able to provide. Several proof-of-concept trials have either been published or been recently presented and many more are in the pipeline suggesting biologic effectiveness of these hybrid devices in reducing restenosis. Local drug delivery technology has already been commercially introduced in some countries for a variety of clinical settings. However, although these technologies offer promise in improving outcomes following lower extremity intervention, caution and safety are paramount. Adequately powered, multicenter, well-designed, randomized controlled trials with long-term follow-up (3-5 years) are still needed to accurately assess safety and efficacy.
authors.affiliation: Division of Vascular and Endovascular Surgery, University of California, San Francisco, 400 Parnassus Ave. A581, San Francisco, CA 94143, USA.
authors.forename: Joy P
authors.initials: JP
authors.lastname: Walker
authors.forename: Christopher D
authors.initials: CD
authors.lastname: Owens
keywords: Drug-coated balloon; Drug-eluting stent; Femoral artery; Local drug delivery; Superficial femoral artery
references.citation: J Vasc Surg. 2005 Sep;42(3):466-75
references.pmid: 16171589
references.citation: J Endovasc Ther. 2009 Jun;16(3):261-9
references.pmid: 19642788
references.citation: J Endovasc Ther. 2006 Dec;13(6):701-10
references.pmid: 17154704
references.citation: Vasc Endovascular Surg. 2006 Dec-2007 Jan;40(6):446-50
references.pmid: 17202090
references.citation: Circ Cardiovasc Interv. 2012 Dec;5(6):831-40
references.pmid: 23192918
references.citation: N Engl J Med. 2008 Feb 14;358(7):689-99
references.pmid: 18272892
references.citation: J Vasc Surg. 2011 Aug;54(2):394-401
references.pmid: 21658885
references.citation: J Vasc Surg. 2005 Nov;42(5):932-9
references.pmid: 16275450
references.citation: J Endovasc Ther. 2012 Feb;19(1):1-9
references.pmid: 22313193
references.citation: J Endovasc Ther. 2011 Oct;18(5):613-23
references.pmid: 21992630
references.citation: Circ Cardiovasc Interv. 2011 Oct 1;4(5):495-504
references.pmid: 21953370
references.citation: Cardiovasc Intervent Radiol. 2013 Apr;36(2):353-61
references.pmid: 23070104
references.citation: J Endovasc Ther. 2002 Feb;9(1):59-66
references.pmid: 11958327
references.citation: Catheter Cardiovasc Interv. 2009 Dec 1;74(7):1090-5
references.pmid: 19859954
references.citation: Arterioscler Thromb Vasc Biol. 1998 Dec;18(12):1958-63
references.pmid: 9848890
references.citation: Radiology. 2002 Aug;224(2):529-35
references.pmid: 12147852
references.citation: Circulation. 2002 Sep 17;106(12):1505-9
references.pmid: 12234956
references.citation: J Vasc Interv Radiol. 2005 Mar;16(3):331-8
references.pmid: 15758128
references.citation: Circulation. 2007 May 29;115(21):2745-9
references.pmid: 17502568
references.citation: Circulation. 2007 Jul 17;116(3):285-92
references.pmid: 17592075
references.citation: Circ Cardiovasc Interv. 2010 Jun 1;3(3):267-76
references.pmid: 20484101
references.citation: J Vasc Surg. 2005 Feb;41(2):269-78
references.pmid: 15768009
references.citation: J Vasc Surg. 2007 Oct;46(4):709-16
references.pmid: 17903651
references.citation: N Engl J Med. 2006 May 4;354(18):1879-88
references.pmid: 16672699
references.citation: Circulation. 2008 Sep 23;118(13):1358-65
references.pmid: 18779447
references.citation: J Am Coll Cardiol. 2005 Jan 18;45(2):312-5
references.pmid: 15653033
references.citation: J Vasc Surg. 2012 Feb;55(2):400-5
references.pmid: 22051872
references.citation: J Vasc Surg. 2006 Oct;44(4):762-9
references.pmid: 17012001